Diurnal variation of bone mineral turnover in elderly men and women

Calcified Tissue International

Volumn 60, Issue 5, 1997, Pages 419-423

  Greenspan, S L ^a   Dresner Pollak, R ^b   Parker, R A ^a   London, D ^a   Ferguson, L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone turnover; Diurnal variation; Elderly; Men; Women

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; COLLAGEN TYPE 1; OSTEOCALCIN; PARATHYROID HORMONE;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE MINERAL; CALCIUM BLOOD LEVEL; CIRCADIAN RHYTHM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CALCIUM; CALCIUM, DIETARY; CIRCADIAN RHYTHM; COLLAGEN; FEMALE; HUMANS; ISOENZYMES; MALE; OSTEOCALCIN; PARATHYROID HORMONE; SEX CHARACTERISTICS; VITAMIN D;

EID: 0030890170     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900256     Document Type: Article

References (22)

1. Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476-480
2. Schlemmer A, Hassager C, Pedersen BJ, Christiansen C (1994) Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J Bone Miner Res 9:1883-1888
3. Eastell R, Calvo MS, Burritt MF, Offord KP, Graham R, Russell G, Riggs BL (1992) Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 74:487-494
4. Greenspan SL, Maitland LA, Myers ER, Krasnow MB, Kido TH (1994) Femoral bone loss progresses with age: a longitudinal study in women over age 65. J Bone Miner Res 9:1959-1965
5. Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR (1992) A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258
6. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367-373
7. Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R (1994) The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 79:730-735
8. Dresner-Pollak R, Maitland LA, Krasnow M, Greenspan SL (1994) Can biochemical markers predict bone loss in elderly women (abstract)? J Bone Miner Res 9(suppl 1):S130
9. Garnero P, Delmas PD (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046-1053
10. Calvo MS, Eastell R, Offord KP, Bergstralh EJ, Burritt MF (1991) Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab 72:69-76
11. Ebeling PR, Jones JD, Burritt MF, Duerson CR, Lane AW, Hassager C, Kumar R, Riggs BL (1992) Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis. J Clin Endocrinol Metab 75:1033-1038
12. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R (1993) Anabolic actions of parathyroid hormone on bone. Endoer Rev 14:690-709
13. Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM (1993) An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 91:1138-1148
14. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM (1994) Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618-1623
15. Lindsay R, Cosman F, Nieves J, Dempster DW, Shen VA (1993) Controlled trial of the effects of 1-34 hPTH in estrogen-treated osteoporotic women (abstract). J Bone Miner Res 8(suppl 1):S130
16. Greenspan SL, Holland S, Maitland-Ramsey L, Poku M, Freeman A, Yuan W, Kher U, Gertz B (1996) Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy. Proc Assoc Am Phys 108:230-238
17. Heaney RP (1994) The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res 9:1515-1523
18. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora II AC, Lombardi A, Shah R, Hirsch LJ, Karpf DB (1995) Effect of treatment with oral alendronate on bone mineral density and fracture incidence in postmenopausal osteoporosis. N Engl J Med 333:1437-1443
19. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S (1995) Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab 80:3304-3310
20. Overgaard K, Hansen MA, Jensen SB, Christiansen C (1992) Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 305:556-561
21. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG (1994) The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366-371
22. Harris ST, Gertz BJ, Genant HK, Eyre DR, Survill TT, Ventura JN, DeBrock J, Ricerca E, Chesnut CH III (1993) The effect of short-term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrinol Metab 76:1399-1406